German Water Utilities Stock News

XTRA:RHM
XTRA:RHMAerospace & Defense

Is Rheinmetall (XTRA:RHM) Still Attractive After Its 44% One Year Share Price Gain?

If you are wondering whether Rheinmetall's recent share price puts it on your watchlist or in the too expensive pile, the key question is what you are actually paying for at today’s levels. With the stock last closing at €1,653.00 and returns of 4.6% over 7 days, 3.0% over 30 days, 3.2% year to date and 44.0% over 1 year, many investors are asking whether the current price still reflects a reasonable entry point or if expectations have already been priced in. Recent headlines around...
XTRA:RWE
XTRA:RWERenewable Energy

RWE (XTRA:RWE) Valuation Check After New Offshore Wind Deals And Renewables Expansion Agreements

RWE (XTRA:RWE) is back in focus after agreeing a 10 year power purchase deal to supply Munich Airport with offshore wind power, alongside fresh turbine contracts for its UK Vanguard offshore projects. See our latest analysis for RWE. These fresh power purchase and turbine agreements come after a strong run in the shares, with a 90 day share price return of 24.56% and a 1 year total shareholder return of 80.25%. This suggests that momentum has been building around RWE’s renewables push. If...
XTRA:IFX
XTRA:IFXSemiconductor

How Investors Are Reacting To Infineon Technologies (XTRA:IFX) Cork R&D Bet On Auto Microelectronics

Infineon Technologies has opened its new R&D Centre in Cork, Ireland, as part of a €60 million investment announced in 2024, focusing on automotive and consumer microelectronics such as battery management, motor control, and touchscreen technologies. This move deepens Infineon’s commitment to technologies that support digitalisation and decarbonisation, while expanding its high-skill engineering footprint and innovation capacity in Ireland. We’ll now examine how this Cork R&D expansion, with...
XTRA:BOSS
XTRA:BOSSLuxury

A Look At Hugo Boss (XTRA:BOSS) Valuation As Mixed Recent Returns Draw Investor Attention

Why Hugo Boss Is on Investor Radars Now Hugo Boss (XTRA:BOSS) has drawn fresh attention after recent trading left the shares with a mixed return picture, including a small 1 day gain alongside weaker year to date and 1 year performance. For you as an investor, that contrast between short term strength and longer term pressure raises questions about how the current price of €35.85 lines up with the company’s earnings profile and broader track record. See our latest analysis for Hugo...
XTRA:MUV2
XTRA:MUV2Insurance

A Look At Munich Re (XTRA:MUV2) Valuation After Higher Dividend And New Share Buyback Program

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has drawn fresh attention after reporting its 2025 results, announcing a €24.00 per share annual dividend and unveiling a share repurchase program of up to €2.25b. See our latest analysis for Münchener Rückversicherungs-Gesellschaft in München. At a share price of €529.8, the stock has seen a 1-day share price return of 1.22% alongside a modest 7-day share price return of 0.99%. Its 1-year total shareholder return of a 2.28%...
XTRA:SRT3
XTRA:SRT3Life Sciences

Assessing Sartorius (XTRA:SRT3) Valuation As Viral Vaccine Media Demand Gains Attention

Why the viral vaccine media outlook matters for Sartorius Fresh analysis pointing to rising demand for viral vaccine cell culture media, supported by more vaccine launches and public funding, puts Sartorius (XTRA:SRT3) back in focus for investors tracking bioprocess suppliers. See our latest analysis for Sartorius. At a share price of €221.1, Sartorius has a 1 day share price return of 3.03%, a 30 day share price return of 7.72% and a 90 day share price return of 12.26%. The 3 year total...
XTRA:EVK
XTRA:EVKChemicals

Evonik Industries (XTRA:EVK) Valuation Check As NOFLU mRNA Flu Vaccine Role Comes Into Focus

Evonik Industries (XTRA:EVK) is back in focus after its role in NOFLU, a European vaccine consortium that just secured an initial €13 million from the European Health and Digital Executive Agency for mRNA flu vaccine development. See our latest analysis for Evonik Industries. The NOFLU announcement lands as Evonik Industries’ share price, currently at €13.88, shows mixed momentum, with a recent 7 day share price return of 2.81% but a 1 year total shareholder return decline of 29.84%, pointing...
XTRA:VOW3
XTRA:VOW3Auto

Is Volkswagen (XTRA:VOW3) Now Pricing In Too Much Pessimism After Recent Share Slide

If you are wondering whether Volkswagen's current share price really reflects what the business is worth, you are not alone. That is exactly what this article will unpack. The stock closed at €90.30 most recently, with returns of a 3.5% decline over 7 days, 10.4% decline over 30 days, 15.2% decline year to date and 11.7% decline over 1 year. The 3 and 5 year returns stand at a 12.9% decline and 32.5% decline, respectively. Recent headlines around Volkswagen have continued to focus on its...
XTRA:AIXA
XTRA:AIXASemiconductor

A Look At AIXTRON (XTRA:AIXA) Valuation After Softer 2025 Results And Cautious 2026 Guidance

AIXTRON (XTRA:AIXA) has given investors fresh information to weigh, with 2025 results showing lower sales and net income compared with the previous year and 2026 revenue guidance pointing to softer business conditions. See our latest analysis for AIXTRON. Despite the softer 2025 results and cautious 2026 guidance, the market reaction has been strong, with a 30 day share price return of 55.66% and a 1 year total shareholder return of 172.52%, suggesting momentum has been building rather than...
XTRA:FNTN
XTRA:FNTNWireless Telecom

A Look At Freenet’s (XTRA:FNTN) Valuation After Higher Dividend And Revenue Growth Outlook

What freenet’s new dividend and revenue outlook mean for shareholders freenet (XTRA:FNTN) has put income and growth in focus, announcing an annual dividend of €2.07 per share alongside guidance that points to significant revenue expansion for 2026. For investors, that combination of a defined cash payout and a more upbeat outlook on the top line raises practical questions about how freenet balances shareholder distributions with its ongoing investment needs in mobile communications and TV and...
XTRA:G1A
XTRA:G1AMachinery

A Look At GEA Group (XTRA:G1A) Valuation After Record 2025 Results And Higher Dividend Proposal

GEA Group (XTRA:G1A) is back in focus after the Executive and Supervisory Boards proposed lifting the dividend to €1.30 per share for 2025, alongside record 2025 results and a completed share buyback. See our latest analysis for GEA Group. The recent dividend proposal and record 2025 figures come after a mixed share price patch, with a 12.09% 90 day share price return and 12.06% 1 year total shareholder return pointing to momentum that has been building rather than fading. If this kind of...
XTRA:OHB
XTRA:OHBAerospace & Defense

A Look At OHB (XTRA:OHB) Valuation After SATCOMBw Stage 4 And Wider Defense Growth Plans

OHB (XTRA:OHB) is back in focus after its role in a proposed consortium with Airbus and Rheinmetall for Germany's multibillion euro SATCOMBw Stage 4 military satellite network sharpened attention on its defense and space pipeline. See our latest analysis for OHB. The proposed SATCOMBw Stage 4 role comes on the back of sharp recent share price moves, with a 90 day share price return of 131.53% and a 1 year total shareholder return of 247.21%. This suggests momentum has been building as...
XTRA:EUZ
XTRA:EUZMedical Equipment

A Look At Eckert & Ziegler (XTRA:EUZ) Valuation After The New Radio DARPin Cancer Therapy Agreement

Radio-DARPin partnership and why it matters for Eckert & Ziegler Molecular Partners has signed an agreement with Eckert & Ziegler (XTRA:EUZ) to develop and manufacture Radio-DARPin therapeutics, enabling targeted delivery of alpha emitting isotopes such as Actinium-225 and Lead-212 to tumors. See our latest analysis for Eckert & Ziegler. The new Radio-DARPin agreement comes after a period where Eckert & Ziegler’s share price has been relatively soft, with a 1 year total shareholder return of...
XTRA:GYC
XTRA:GYCReal Estate

Aroundtown Offer Puts Grand City Properties Valuation And Control In Focus

Aroundtown has launched a voluntary public exchange offer to acquire an additional stake in Grand City Properties. The Board of Grand City Properties has publicly supported the offer. The move introduces fresh M&A considerations for shareholders in XTRA:GYC. For you as a shareholder, the Aroundtown exchange offer puts Grand City Properties (XTRA:GYC) in the middle of a potential change in control discussion at a time when the stock trades around €9.87. Over 3 years, the share price return...
XTRA:BEI
XTRA:BEIPersonal Products

Assessing Beiersdorf (XTRA:BEI) Valuation After Its Shift To 100% Recycled Aluminium Aerosol Cans

Beiersdorf (XTRA:BEI) is drawing fresh attention after converting all its European aerosol cans to 100% post consumer recycled aluminium in partnership with Ball Corporation. The move is tied directly to its long term net zero plans. See our latest analysis for Beiersdorf. Those sustainability headlines arrive during a weak patch for the shares, with a 7 day share price return of 22.69% and a 30 day share price return of 21.61%. This has contributed to a 1 year total shareholder return of...
XTRA:AG1
XTRA:AG1Specialty Retail

A Look At AUTO1 Group’s (XTRA:AG1) Valuation After Updated 2026 Production Guidance

Updated production outlook and what it could mean for investors AUTO1 Group (XTRA:AG1) has issued new production guidance for 2026, projecting total units between 940,000 and 1,000,000, with both Merchant and Retail segments expected to be above their 2025 unit levels. For investors, this updated outlook places upcoming volume execution in focus, as the company targets 815,000 to 865,000 units in Merchant and 125,000 to 135,000 units in Retail for the year. See our latest analysis for AUTO1...
XTRA:P911
XTRA:P911Auto

A Look At Porsche (XTRA:P911) Valuation After Sustained Share Price Weakness

Recent share performance in context Dr. Ing. h.c. F. Porsche (XTRA:P911) has drawn fresh attention after a period of weak share performance, with the stock showing negative returns over the past day, week, month, past 3 months, year to date and past year. With the last close at €36.45, investors are weighing this sustained share price pressure against the company’s most recent annual revenue of €38.383b and net income of €952m, as well as its current value score of 2. See our latest analysis...
XTRA:ENR
XTRA:ENRElectrical

Is It Time To Rethink Siemens Energy (XTRA:ENR) After A 195% One Year Surge?

If you are wondering whether Siemens Energy's share price reflects its underlying value or has moved ahead of itself, you are not alone. This article will walk through what the current market price might be implying. The stock has seen a mixed pattern recently, with an 8.4% decline over the last 7 days and a 2.1% decline over the last 30 days, set against a 21.1% gain year to date and a very large 1 year return of 195.5% that has lifted it several times higher over 3 years. Recent headlines...
XTRA:CBK
XTRA:CBKBanks

Commerzbank (XTRA:CBK) Valuation Check After Recent Pullback And Digital Growth Narrative

What Commerzbank’s Recent Returns Tell You Commerzbank (XTRA:CBK) has seen a mix of returns recently, including 1-day, weekly, monthly and past 3-month performance data that may prompt investors to reassess how its shares fit into their portfolio. Over the past year, the stock shows a total return figure alongside a multiyear track record, including 3-year and 5-year total return numbers. This offers context on how recent moves compare with longer-term performance. See our latest analysis for...
XTRA:AOF
XTRA:AOFSoftware

Assessing ATOSS Software (XTRA:AOF) Valuation After Its Shift To Recurring Cloud And Software Revenue

ATOSS Software (XTRA:AOF) is drawing investor attention after its business model shifted further toward recurring software fees and cloud subscriptions, a move that directly ties into its current growth and profitability profile. See our latest analysis for ATOSS Software. After a strong run in recent sessions, with a 1-week share price return of 5.87% and a 1-month share price return of 6.24%, ATOSS Software still sits well below its recent highs. This comes after a 90-day share price...
XTRA:LEG
XTRA:LEGReal Estate

Assessing LEG Immobilien (XTRA:LEG) Valuation After Strong Earnings And Higher Dividend Announcement

LEG Immobilien (XTRA:LEG) has drawn fresh attention after reporting full year 2025 earnings and confirming an annual dividend of €2.92 per share, with payment scheduled for June 1, 2026. See our latest analysis for LEG Immobilien. LEG Immobilien’s share price has held at €65.35 after the earnings and dividend announcements, with a 30 day share price return of 5.74% and a 90 day gain of 6.09%. The 3 year total shareholder return of 20.73% contrasts with a 5 year total shareholder return...
XTRA:DHL
XTRA:DHLLogistics

Assessing Deutsche Post (XTRA:DHL) Valuation After Earnings Growth And Dividend Increase

Earnings and dividend move keep Deutsche Post (XTRA:DHL) in focus Deutsche Post (XTRA:DHL) has attracted attention after reporting full year 2025 results, a higher annual dividend, and progress on its Fit for Growth cost program supported by AI and digitalization. See our latest analysis for Deutsche Post. Despite the fresh earnings and dividend news, Deutsche Post’s share price has had a softer patch recently, with a 7.10% 1 month share price return and a 5.14% 7 day share price return. Even...
XTRA:HLAG
XTRA:HLAGShipping

Hapag-Lloyd (XTRA:HLAG) Valuation In Focus After Recent Boardroom Leadership Changes

Hapag-Lloyd (XTRA:HLAG) is back in focus after a series of boardroom changes, with long-serving chairman Michael Behrendt stepping back due to illness and Karl Gernandt taking over the supervisory board leadership. See our latest analysis for Hapag-Lloyd. The governance reshuffle comes as the stock trades at €140.5, with a 30 day share price return of 17.28% and a 1 year total shareholder return of 2.32%. The 3 year total shareholder return of 31.80% and 5 year total shareholder return of...
XTRA:RDC
XTRA:RDCConsumer Retailing

A Look At Redcare Pharmacy (XTRA:RDC) Valuation After Earnings Reveal Growth And Ongoing Margin Pressures

Why Redcare Pharmacy’s latest earnings moved the stock Redcare Pharmacy (XTRA:RDC) shares reacted sharply after the company reported full year 2025 earnings, with higher sales of €2.94b, a narrower net loss of €37.7m, and fresh guidance for 2026. The market response, including a 21.01% one day drop in the share price, reflected investor focus on margin pressures, mixed cash flow signals, and how the new growth targets might affect profitability. See our latest analysis for Redcare...